Amgen And Health And Benefits Consultant Piper Jordan Partner On First Migraine Project With Employers Read more about Amgen And Health And Benefits Consultant Piper Jordan Partner On First Migraine Project With Employers
Amgen And Novartis Highlight Findings From A Large Global Patient Survey Revealing That Worldwide Approximately 60 Percent Of Employed People With Migraine Missed, On Average, A Week Of Work In A Month Read more about Amgen And Novartis Highlight Findings From A Large Global Patient Survey Revealing That Worldwide Approximately 60 Percent Of Employed People With Migraine Missed, On Average, A Week Of Work In A Month
Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab Read more about Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab
New Data Show Amgen's Repatha® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes Read more about New Data Show Amgen's Repatha® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes
Amgen Receives European Commission Approval To Add Overall Survival Data To BLINCYTO® (blinatumomab) Label Read more about Amgen Receives European Commission Approval To Add Overall Survival Data To BLINCYTO® (blinatumomab) Label
FDA Approves Addition Of Positive Overall Survival Data From Phase 3 ASPIRE Trial To KYPROLIS® (carfilzomib) Label Read more about FDA Approves Addition Of Positive Overall Survival Data From Phase 3 ASPIRE Trial To KYPROLIS® (carfilzomib) Label
Amgen To Present At The Goldman Sachs 39th Annual Global Healthcare Conference Read more about Amgen To Present At The Goldman Sachs 39th Annual Global Healthcare Conference
European Commission Approves Prolia® (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis Read more about European Commission Approves Prolia® (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
Amgen, Oklahoma Health Care Authority And University of Oklahoma's Pharmacy Management Consultants Partner To Improve Medicaid Outcomes Read more about Amgen, Oklahoma Health Care Authority And University of Oklahoma's Pharmacy Management Consultants Partner To Improve Medicaid Outcomes
Preventing Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations Read more about Preventing Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations
